Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice.

Eva Galíndez-Agirregoikoa Diana Prieto-PeñaJosé Luis Martín-VarillasBeatriz Joven Olga Rusinovich Rafael Benito Melero-González Francisco Ortiz-SanjuanRaquel AlmodóvarJuan José Alegre SanchoÁngels MartínezAgustí Sellas FernandezLara MéndezRosario García de Vicuña Belen Atienza-MateoIñigo GorostizaMiguel Angel González-Gay Ricardo Blanco-Alonsonull null

Published in: The Journal of rheumatology (2021)

Data from clinical practice confirm that TOF seems to be effective, rapid, and relatively safe in refractory PsA despite clinical differences with patients in RCTs.

Keyphrases

end stage renal disease
clinical practice
chronic kidney disease
ejection fraction
newly diagnosed
prostate cancer
prognostic factors
peritoneal dialysis
mass spectrometry
radical prostatectomy
data analysis